Ionis: Recent Approvals, Upcoming Catalysts To Spur Strong Upside (Rating Upgrade)

Core Insights - The article reflects on the author's long-term investment journey, particularly focusing on Ionis Pharmaceuticals and its stock performance over the years [1]. Group 1 - The author has written a total of twelve articles about Ionis, indicating a sustained interest and analysis of the company's developments [1]. - The investment approach is described as a learning process, where both successes and failures contribute to the overall understanding of the market [1]. - The author emphasizes the importance of sharing experiences and insights within the investment community, particularly regarding healthcare stocks [1].